Ülke: Birleşik Krallık
Dil: İngilizce
Kaynak: HMA (Heads of Medicines Agencies)
moxidectin 18.92 mg
Pfizer Animal Health
QP54AB02
Oral gel
moxidectin
Horses
2012-02-21
1 SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE VETERINARY MEDICINAL PRODUCT EQUEST ORAL GEL, 18,92 mg/g, oral gel for horses and ponies (Sweden: Cydectin Vet) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Qualitative composition Quantitative composition Each g contains: ACTIVE SUBSTANCE: Moxidectin 18.92 mg EXCIPIENTS QSP: Benzyl Alcohol (E1519) Disodium Edetate 37.84 mg 0.24 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral Gel. Yellow Gel. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses and ponies. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES The veterinary medicinal product is indicated for treatment of infections caused by moxidectin sensitive strains of: Large strongyles: _Strongylus vulgaris_ (adults and arterial stages) _Strongylus edentatus_ (adults and visceral stages) _Triodontophorus brevicauda_ (adults) _Triodontophorus serratus_ (adults) _Triodontophorus tenuicollis _ (adults) Small strongyles (adults and intraluminal larval stages): _Cyathostomum _spp. _Cylicocyclus _spp_._ _Cylicostephanus _spp_._ _Cylicodontophorus_ spp. _Gyalocephalus _spp. Ascarids: _Parascaris equorum_ (adult and larval stages) 3 Other species: _Oxyuris equi _(adult and larval stages) _Habronema muscae _(adults)_ _ _Gasterophilus intestinalis _(L2, L3) _Gasterophilus nasalis _(L2, L3) _Strongyloides westeri _(adults) _Trichostrongylus axei_ The veterinary medicinal product has a persistent efficacy Belgenin tamamını okuyun